Why do we need a three-dimensional architecture of the ligand-binding domain of the nuclear 1α,25-dihydroxyvitamin D3 receptor?☆
Authors:
- 9 February 2001
- Vol. 66 (3-5) , 189-201
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Ligand-dependent transcription activation by nuclear receptors requires the DRIP complexNature, 1999
- Current Understanding of the Molecular Actions of Vitamin DPhysiological Reviews, 1998
- Receptors for 1α,25(OH)2D3: Past, Present, and FutureJournal of Bone and Mineral Research, 1998
- Conformation−Function Relationship of Vitamin D: Conformational Analysis Predicts Potential Side-Chain StructureJournal of Medicinal Chemistry, 1998
- The Nuclear Vitamin D Receptor: Biological and Molecular Regulatory Properties RevealedJournal of Bone and Mineral Research, 1998
- Crystal and molecular structure of 1,25-dihydroxycholecalciferolActa crystallographica Section B, Structural science, crystal engineering and materials, 1996
- Conformationally Restricted Analogs of 1α,25-Dihydroxyvitamin D3 and Its 20-Epimer: Compounds for Study of the Three-Dimensional Structure of Vitamin D Responsible for Binding to the ReceptorJournal of Medicinal Chemistry, 1996
- Conformational analysis of 1α,25-dihydroxyvitamin D3 by nuclear magnetic resonanceBioorganic Chemistry, 1990
- Synthesis of a photoaffinity-labelled analogue of 1,25-dihydroxyvitamin D3Journal of the Chemical Society, Chemical Communications, 1985
- Evidence for a reactive sulfhydryl in the DNA binding domain of the 1,25-dihydroxyvitamin D3 receptorBiochemical and Biophysical Research Communications, 1981